The acute chest syndrome of sickle cell disease

Expert Opinion on Pharmacotherapy

Volumn 14, Issue 8, 2013, Pages 991-999

  Desai, Payal C ^a   Ataga, Kenneth I ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Acute chest syndrome; Pathogenesis; Prevention; Pulmonary complications; Sickle cell disease; Treatment

Indexed keywords

ANALGESIC AGENT; CEPHALOSPORIN; CORTICOSTEROID; HEME OXYGENASE 1; HEMOGLOBIN; MACROLIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PENICILLIN DERIVATIVE; SECRETORY PHOSPHOLIPASE A2; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE CHEST SYNDROME; ARTERIAL GAS; BLOOD CELL COUNT; BLOOD CULTURE; COUGHING; DISEASE ASSOCIATION; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; FAT EMBOLISM; FEVER; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FUNCTION; LEUKOCYTE COUNT; LIVER FUNCTION; MULTICENTER STUDY (TOPIC); OXYGEN DESATURATION; PAIN; PHYSICAL EXAMINATION; PNEUMOCOCCAL INFECTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REHYDRATION; RETICULOCYTE COUNT; REVIEW; SICKLE CELL ANEMIA; SPUTUM CULTURE; THORAX PAIN; THORAX RADIOGRAPHY; THROMBOCYTE COUNT;

ACUTE CHEST SYNDROME; ANIMALS; HUMANS;

EID: 84877644197     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2013.783570     Document Type: Review

References (95)

1. Gray A, Anionwu EN, Davies SC, Brozovic M. Patterns of mortality in sickle cell disease in the United Kingdom. J Clin Pathol 1991;44:459-63
2. Lee A, Thomas P, Cupidore L, et al. Improved survival in homozygous sickle cell disease: Lessons from a cohort study. BMJ 1995;311:1600-2
3. Manci EA, Culberson DE, Yang YM, et al. Causes of death in sickle cell disease: An autopsy study. Br J Haematol 2003;123:359-65
4. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease -life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-44
5. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood 2004;103:4023-7
6. Rogers DW, Clarke JM, Cupidore L, et al. Early deaths in Jamaican children with sickle cell disease. BMJ 1978;1:1515-16
7. Thomas AN, Pattison C, Serjeant GR. Causes of death in sickle-cell disease in Jamaica. BMJ (Clin Res Ed) 1982;285:633-5
8. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med 1997;337:762-9
9. Ergul S, Brunson CY, Hutchinson J, et al. Vasoactive factors in sickle cell disease: In vitro evidence for endothelin 1 mediated vasoconstriction. Am J Hematol 2004;76:245-51
10. Kaul DK, Fabry ME, Costantini F, et al. In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse. J Clin Invest 1995;96:2845-53
11. Steinberg MH. Management of sickle cell disease. N Engl J Med 1999;340:1021-30
12. Minter KR, Gladwin MT. Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research. Am J Respir Crit Care Med 2001;164:2016-19
13. Siddiqui AK, Ahmed S. Pulmonary manifestations of sickle cell disease. Postgrad Med J 2003;79:384-90
14. Charache S, Scott JC, Charache P. " ;Acute chest syndrome" ; in adults with sickle cell anemia. Microbiology, treatment, and prevention. Arch Intern Med 1979;139:67-9
15. Platt OS. The acute chest syndrome of sickle cell disease. N Engl J Med 2000;342:1904-7
16. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. N Engl J Med 2000;342:1855-65
17. Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome in sickle cell disease: Incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 1994;84:643-9
18. Ballas SK, Lieff S, Dampier CD, et al. Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol 2010;85(1):6-13
19. Boyd JH, Macklin EA, Strunk RC, DeBaun MR. Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood 2006;108:2923-7
20. Poulter EY, Truszkowski P, Thrombson AA, Liem RI. Acute chest syndrome is associated with history of asthma in hemoglobin SC disease. Pediatr Blood Cancer 2011;57:289-93
21. Bernaudin F, Strunk RC, Kamdem A, et al. Asthma is associated with acute chest syndrome, but not with an increased rate of hospitalization for pain among children in France with sickle cell anemia: A retrospective cohort study. Haematologica 2008;93:1917-18
22. Sylvester KP, Patey RA, Rafferty GF, et al. Airway hyperresponsiveness and acute chest syndrome in children with sickle cell anemia. Pediatr Pulmonol 2007;42:272-6
23. Nordness ME, Lynn J, Zacharisen MC, et al. Asthma is a risk factor for acute chest syndrome and cerebral vascular accidents in children with sickle cell disease. Clin Mol Allergy 2005;3:2
24. Boyd JH, Macklin EA, Strunk RC, DeBaun MR. Asthma is associated with increased mortality in individuals with sickle cell anemia. Haematologica 2007;92:1115-18
25. Knight-Madden JM, Forrester TS, Lewis NA, Greenough A. Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax 2005;60:206-10
26. Cohen RT, DeBaun MR, Blinder MA, et al. Smoking is associated with an increased risk of acute chest syndrome and pain among adults with sickle cell disease. Blood 2010;115:3852-4
27. Young RC Jr, Rachal RE, Hackney RL Jr, et al. Smoking is a factor in causing acute chest syndrome in sickle cell anemia. J Natl Med Assoc 1992;84:267-71
28. Vichinsky EP, Styles LA, Colangelo LH, et al. Acute chest syndrome in sickle cell disease: Clinical presentation and course. Blood 1997;89:1787-92
29. Bean CJ, Boulet SL, Ellingsen D, et al. Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease. Blood 2012;120:3822-8
30. Hirai H, Kubo H, Yamaya M, et al. Microsatellite polymorphism in heme oxygenase-1 gene promoter is associated with susceptibility to oxidant-induced apoptosis in lymphoblastoid cell lines. Blood 2003;102:1619-21
31. Taha H, Skrzypek K, Guevara I, et al. Role of heme oxygenase-1 in human endothelial cells: Lesson from the promoter allelic variants. Arterioscler Thromb Vasc Biol 2010;30:1634-41
32. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood 1998;91:288-94
33. Henderson JN, Noetzel MJ, McKinstry RC, et al. Reversible posterior leukoencephalopathy syndrome and silent cerebral infarcts are associated with severe acute chest syndrome in children with sickle cell disease. Blood 2003;101:415-19
34. Quinn CT, McKinstry RC, Dowling MM, et al. Acute silent ischemic events in children with sickle cell anemia. JAMA Neurol 2013;70:58-65
35. Davies SC, Win AA, Luce PJ, et al. Acute chest syndrome in sickle-cell disease. Lancet 1984;323:36-8
36. Stuart MJ, Setty BN. Sickle cell acute chest syndrome: Pathogenesis and rationale for treatment. Blood 1999;94:1555-60
37. Vichinsky E, Styles L. Pulmonary complications. Hematol Oncol Clin North Am 1996;10:1275-87
38. Vichinsky E, Williams R, Das M, et al. Pulmonary fat embolism: A distinct cause of severe acute chest syndrome in sickle cell anemia. Blood 1994;83:3107-12
39. Miller AC, Subramanian RA, Safi F, et al. Influenza A 2009 (H1N1) virus in admitted and critically Ill patients. J Intensive Care Med 2012;27:25-31
40. Strouse JJ, Reller ME, Bundy DG, et al. Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell disease. Blood 2010;116:3431-4
41. Ataga KI, Orringer EP. Bone marrow necrosis in sickle cell disease: A description of three cases and a review of the literature. Am J Med Sci 2000;320:342-7
42. Hassell KL, Eckman JR, Lane PA. Acute multiorgan failure syndrome: A potentially catastrophic complication of severe sickle cell pain episodes. Am J Med 1994;96:155-62
43. Kuypers FA, Lewis RA, Hua M, et al. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood 1996;87:1179-87
44. Kuypers FA, Styles LA. The role of secretory phospholipase A2 in acute chest syndrome. Cell Mol Biol (Noisy-legrand) 2004;50:87-94
45. Styles LA, Aarsman AJ, Vichinsky EP, Kuypers FA. Secretory phospholipase A2 predicts impending acute chest syndrome in sickle cell disease. Blood 2000;96:3276-8
46. Styles LA, Schalkwijk CG, Aarsman AJ, et al. Phospholipase A2 levels in acute chest syndrome of sickle cell disease. Blood 1996;87:2573-8
47. Styles L, Wager CG, Labotka RJ, et al. Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: Results of a feasibility study (PROACTIVE). Br J Haematol 2012;157:627-36
48. Margolies MP. Sickle cell anemia: A composite study and survey. Medicine 1951;30:357-433
49. Dessap AM, Deux J-F, Abidi N, et al. Pulmonary artery thrombosis during acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med 2011;184:1022-9
50. Ballas SK, Park CH. Severe hypoxemia secondary to acute sternal infarction in sickle cell anemia. J Nucl Med 1991;32:1617-18
51. Charache S, Page DL. Infarction of bone marrow in the sickle cell disorders. Ann Intern Med 1967;67:1195-200
52. Rucknagel DL. The role of rib infarcts in the acute chest syndrome of sickle cell diseases. Pediatr Pathol Mol Med 2001;20:137-54
53. Haynes J, Allison RC. Pulmonary edema complications in the management of sickle cell pain crisis. Am J Med 1986;80:833-40
54. Gladwin MT, Schechter AN, Shelhamer JH, Ognibene FP. The acute chest syndrome in sickle cell disease. Possible role of nitric oxide in its pathophysiology and treatment. Am J Respir Crit Care Med 1999;159:1368-76
55. Gladwin MT, Vichinsky E. Pulmonary complications of sickle cell disease. N Engl J Med 2008;359:2254-65
56. Hebbel RP. Beyond hemoglobin polymerization: The red blood cell membrane and sickle disease pathophysiology. Blood 1991;77:214-37
57. Ghosh S AO, Aryee D, Tan F, Ofori-Acquah S. Heme induced organ failure in sickle cell disease is spatiotemporally determined by the amount of heme released into the bloodstream. Blood 2011(Meeting/Abstract):abstract 2135
58. Setty BN, Stuart MJ. Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: Potential role in sickle cell disease. Blood 1996;88:2311-20
59. Stuart MJ, Setty BN. Acute chest syndrome of sickle cell disease: New light on an old problem. Curr Opin Hematol 2001;8:111-22
60. Gladwin MT, Rodgers GP. Pathogenesis and treatment of acute chest syndrome of sickle-cell anaemia. Lancet 2000;355:1476-8
61. Ghosh S, Ofori-Acquah S. Acute chest syndrome in transgenic mouse models of sickle cell disease triggered by free heme American journal of respiratory and critical care medicine. Blood 2010(MeetingAbstracts):abstract 944
62. Reagan MM, DeBaun MR, Frei-Jones MJ. Multi-modal intervention for the inpatient management of sickle cell pain significantly decreases the rate of acute chest syndrome. Pediatr Blood Cancer 2011;56:262-6
63. Haynes J Jr, Allison RC. Pulmonary edema: Complication in the management of sickle cell pain crisis. Am J Med 1986;80:833-40
64. Quinn CT, Buchanan GR. The acute chest syndrome of sickle cell disease. J Pediatr 1999;135:416-22
65. Cole TB, Sprinkle RH, Smith SJ, Buchanan GR. Intravenous narcotic therapy for children with severe sickle cell pain crisis. Am J Dis Child 1986;140:1255-9
66. Needleman JP, Benjamin LJ, Sykes JA, Aldrich TK. Breathing patterns during vaso-occlusive crisis of sickle cell disease. Chest 2002;122:43-6
67. Palmer J, Broderick KA, Naiman JL. Acute lung syndrome during painful sickle cell crisis: Relation to site of pain and narcotic requirement. Blood 1983;62(Suppl 1):59a
68. 68. Bellet PS, Kalinyak KA, Shukla R, et al. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med 1995;333:699-703
69. Ahmad FA, Marcias CG, Allen JY. The use of incentive spirometry in pediatric patients with sickle cell disease to reduce the incidence of acute chest syndrome. J Pediatr Hematol Oncol 2011;33:415-20
70. Ahmed S, Siddiqui AK, Sison CP, et al. Hemoglobin oxygen saturation discrepancy using various methods in patients with sickle cell vaso-occlusive painful crisis. Eur J Haematol 2005;74:309-14
71. Kress JP, Pohlman AS, Hall JB. Determination of hemoglobin saturation in patients with acute sickle chest syndrome. Chest 1999;115:1316-20
72. Ortiz FO, Aldrich TK, Nagel RL, Benjamin LJ. Accuracy of pulse oximetry in sickle cell disease. Am J Respir Crit Care Med 1999;159:447-51
73. Fawibe AE. Managing acute chest syndrome of sickle cell disease in an African setting. Trans R Soc Trop Med Hyg 2008;102:526-31
74. Knight J, Murphy TM, Browning I. The lung in sickle cell disease. Pediatr Pulmonol 1999;28:205-16
75. Wong WY, Powars DR, Chan L, et al. Polysaccharide encapsulated bacterial infection in sickle cell anemia: A thirty year epidemiologic experience. Am J Hematol 1992;39:176-82
76. Falletta JM, Woods GM, Verter JI, et al. Discontinuing penicillin prophylaxis in children with sickle cell anemia. J Pediatr 1995;127:685-90
77. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. N Engl J Med 1986;314:1593-9
78. Ammann AJ, Addiego J, Wara DW, et al. Polyvalent pneumococcal- polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy. N Engl J Med 1977;297:897-900
79. Marcinak JF, Frank AL, Labotka RL, et al. Immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in 3-To 17-month-old infants with sickle cell diseases. J Pediatr 1991;118:69-71
80. Vernacchio L, Neufeld EJ, MacDonald K, et al. Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease. J Pediatr 1998;133:275-8
81. Wong WY, Overturf GD, Powars DR. Infection caused by Streptococcus pneumoniae in children with sickle cell disease: Epidemiology, immunologic mechanisms, prophylaxis, and vaccination. Clin Infect Dis 1992;14:1124-36
82. Emre U, Miller ST, Gutierez M, et al. Effect of transfusion in acute chest syndrome of sickle cell disease. J Pediatr 1995;127:901-4
83. Maitre B, Habibi A, Roudot-Thoraval F, et al. Acute chest syndrome in adults with sickle cell disease. Chest 2000;117:1386-92
84. Styles LA, Abboud M, Larkin S, et al. Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. Br J Haematol 2007;136:343-4
85. Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990;76:1431-7
86. Vichinsky EP, Earles A, Johnson RA, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990;322:1617-21
87. Yazdanbakhsh K, Ware RE, Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: Pathophysiology, risk factors, and transfusion management. Blood 2012;120:528-37
88. Bernini JC, Rogers ZR, Sandler ES, et al. Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood 1998;92:3082-9
89. Griffin TC, McIntire D, Buchanan GR. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease. N Engl J Med 1994;330:733-7
90. Sobota A, Graham DA, Heeney MM, Neufeld EJ. Corticosteroids for acute chest syndrome in children with sickle cell disease: Variation in use and association with length of stay and readmission. Am J Hematol 2010;85:24-8
91. Strouse JJ, Takemoto CM, Keefer JR, et al. Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease. Pediatr Blood Cancer 2008;50:1006-12
92. Atz AM, Wessel DL. Inhaled nitric oxide in sickle cell disease with acute chest syndrome. Anesthesiology 1997;87:988-90
93. Chang WL, Corate LM, Sinclair JM, van der Heyde HC. Continuous inhaled nitric oxide therapy in a case of sickle cell disease with multiorgan involvement. J Investig Med 2008;56:1023-7
94. Sullivan KJ, Goodwin SR, Evangelist J, et al. Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Crit Care Med 1999;27:2563-8
95. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995;332:1317-22